CTIM-28. NEOADJUVANT ANTI-PD1 IMMUNOTHERAPY FOR SURGICALLY ACCESSIBLE RECURRENT GLIOBLASTOMA: CLINICAL AND MOLECULAR OUTCOMES OF A STAGE 2 SINGLE-ARM EXPANSION COHORT

Authors: J Ricardo McFaline-Figueroa, Lu Sun, Gilbert Youssef, Raymond Huang, Gang Li, Jiyoon Kim, Eudocia Lee, Lakshmi Nayak, Ugonma Chukwueke, Rameen Beroukhim, Tracy Batchelor, E Antonio Chiocca, Richard Everson, Lisa Doherty, Jennifer Stefanik, Kathryn Partridge, Amanda Spearman, Alexa Myers, Catharina Westergaard, Alyssa Russ, Maria Lavallee, Anna Smokovich, Corey LaForest-Roys, Rachel Garcia Fox, Christine McCluskey, Wenya Linda Bi, Omar Arnaout, PierPaolo Peruzzi, G Rees Cosgrove, Keith Ligon, Isabel Arrillaga Romany, Jennifer Clarke, David Reardon, Timothy Cloughesy, Robert Prins, Patrick Wen

Published: 2024-11-11

DOI: 10.1093/neuonc/noae165.0361

Source: Full article


Abstract

Abstract